These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 827023)

  • 41. [Significance of CA 125 antigen levels in patients with ovarian cancer].
    Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Tumor markers in epithelial carcinoma of the ovary].
    Cottini M; Carnino F; Iskra L; Rapisarda V; Mossetti C
    Minerva Ginecol; 1986 Jun; 38(6):479-84. PubMed ID: 3461313
    [No Abstract]   [Full Text] [Related]  

  • 43. Immunomodulation in patients with epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes.
    Ikarashi H; Fujita K; Takakuwa K; Kodama S; Tokunaga A; Takahashi T; Tanaka K
    Cancer Res; 1994 Jan; 54(1):190-6. PubMed ID: 8261438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
    Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
    Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CA54/61 as a marker for epithelial ovarian cancer.
    Nozawa S; Aoki D; Yajima M; Tsukazaki K; Kobayashi T; Kimura E; Terashima Y; Inaba N; Takamizawa H; Negishi Y
    Cancer Res; 1992 Mar; 52(5):1205-9. PubMed ID: 1737381
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Immunochemical identification of a new embryonal antigen in ovarian tumor tissue].
    Kalashnikov VV; Borisenko SA; Tatarinov IS
    Biull Eksp Biol Med; 1976 Jun; 81(6):725-6. PubMed ID: 953311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification, purification, and radioimmunoassay of NB/70K, a human ovarian tumor-associated antigen.
    Knauf S; Urbach GI
    Cancer Res; 1981 Apr; 41(4):1351-7. PubMed ID: 6163521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carcinoembryonic antigen in human ovarian neoplasms.
    Marchand A; Fenoglio CM; Pascal R; Richart RM; Bennett S
    Cancer Res; 1975 Dec; 35(12):3807-10. PubMed ID: 1192434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cellular specificity of NB70K, a putative human ovarian tumor antigen.
    Bizzari JP; Mackillop WJ; Buick RN
    Cancer Res; 1983 Feb; 43(2):864-7. PubMed ID: 6336660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Possibility of immunodiagnosis in ovarian cancer.
    Chin Med J (Engl); 1978 May; 4(3):185-90. PubMed ID: 98299
    [No Abstract]   [Full Text] [Related]  

  • 51. Heterophile antigens in serous cystadenocarcinoma of the human ovary.
    Kamada M; Mori T; Sakamoto Y; Daitoh T; Furumoto H; Irahara M; Aono T; Mori T
    Asia Oceania J Obstet Gynaecol; 1992 Dec; 18(4):387-95. PubMed ID: 1283511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell-mediated immunity to human malignant cells. A brief review and further studies with two gynecologic tumors.
    DiSaia PJ; Sinkovics JG; Rutledge FN; Smith JP
    Am J Obstet Gynecol; 1972 Dec; 114(7):979-89. PubMed ID: 4118903
    [No Abstract]   [Full Text] [Related]  

  • 53. Ovarian tumours markers: clinical experiences.
    Maggino T; Tredese F; Paternoster D; Marchesoni D; Valente S; Inguscio D; Marchetti M
    Eur J Gynaecol Oncol; 1982; 3(2):81-7. PubMed ID: 6187572
    [No Abstract]   [Full Text] [Related]  

  • 54. Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid.
    Rao GS; Hanjani P
    Am J Obstet Gynecol; 1988 Jul; 159(1):94-8. PubMed ID: 3394756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Demonstration of tumor-associated antigens in human gynecologic malignancies.
    Gall SA; Walling J; Pearl J
    Am J Obstet Gynecol; 1973 Feb; 115(3):387-93. PubMed ID: 4630174
    [No Abstract]   [Full Text] [Related]  

  • 56. The development of a double-antibody radioimmunoassay for detecting ovarian tumor-associated antigen fraction OCA in plasma.
    Knauf S; Urbach GI
    Am J Obstet Gynecol; 1978 Aug; 131(7):780-7. PubMed ID: 686071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A study of ovarian cancer patients using a radioimmunoassay for human ovarian tumor-associated antigen OCA.
    Knauf S; Urbach GI
    Am J Obstet Gynecol; 1980 Dec; 138(8):1222-3. PubMed ID: 7446632
    [No Abstract]   [Full Text] [Related]  

  • 58. Identification of tumor-associated antigens and their purification for cyst fluids of ovarian epithelial neoplasms.
    Dawson JR; Kutteh WH; Whitesides DB; Gall SA
    Gynecol Oncol; 1980 Aug; 10(1):6-17. PubMed ID: 6772525
    [No Abstract]   [Full Text] [Related]  

  • 59. Purification of human ovarian tumor-associated antigen and demonstration of circulating tumor antigen in patients with advanced ovarian malignancy.
    Knauf S; Urbach GI
    Am J Obstet Gynecol; 1977 Apr; 127(7):705-10. PubMed ID: 66873
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antigenicity of papillary serous cystadenocarcinoma tissue culture cells.
    Levi MM; Parshley MS; Mandl I
    Am J Obstet Gynecol; 1968 Oct; 102(3):433-9. PubMed ID: 4970936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.